1. Home
  2. OPTX vs CRVO Comparison

OPTX vs CRVO Comparison

Compare OPTX & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Syntec Optics Holdings Inc.

OPTX

Syntec Optics Holdings Inc.

HOLD

Current Price

$2.95

Market Cap

91.6M

Sector

Finance

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$7.95

Market Cap

78.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPTX
CRVO
Founded
1981
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.6M
78.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OPTX
CRVO
Price
$2.95
$7.95
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$21.50
AVG Volume (30 Days)
5.6M
45.5K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,900,395.00
$6,159,786.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.92
52 Week High
$3.59
$16.94

Technical Indicators

Market Signals
Indicator
OPTX
CRVO
Relative Strength Index (RSI) 64.83 46.77
Support Level $2.80 $7.43
Resistance Level $3.59 $8.46
Average True Range (ATR) 0.43 0.52
MACD 0.12 -0.05
Stochastic Oscillator 72.93 47.62

Price Performance

Historical Comparison
OPTX
CRVO

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: